GC19182
GSK2982772
Also known as 5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide
GSK2982772 is a potent and ATP competitive RIP1 inhibitor with an IC50 of 16 nM
ChemicalCAS1622848-92-3MW377.4FormulaC20H19N5O3
- CAS number
- 1622848-92-3
- Molecular weight
- 377.4
- Formula
- C20H19N5O3
- Solubility
- DMSO ： ≥ 100 mg/mL (264·97 mM)
- InChIKey
- LYPAFUINURXJSG-AWEZNQCLSA-N
- Catalogue number
- GC19182
- Brand
- GLPBIO
Computed properties PubChem CID 77108121 · XLogP 2.4 · TPSA 100 Ų · H-bond donors 2
- XLogP
- 2.4
- TPSA
- 100 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 28
SMILES CN1C2=CC=CC=C2OC[C@@H](C1=O)NC(=O)C3=NNC(=N3)CC4=CC=CC=C4
Computed descriptors from PubChem (CID 77108121), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il